Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-20+235,541→ 235,541 totalExercise: $6.65Exp: 2032-01-19→ Common Stock (235,541 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 20, 2022 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.